Table TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 [see all tables in this series...]

Part (vii) Percentage distribution of route of administration amongst all clients with stimulants (other than cocaine) as primary drug

Country		Inject	Smoke/inhale	Eat/drink	Sniff	Others	Base (known status)	Status unknown
Bulgaria		0.0	0.0	18.2	81.8	0.0	11	0
Czech Republic		71.1	1.2	1.9	25.8	0.0	949	25
Denmark		1.2	0.0	20.7	78.0	0.0	246	71
Germany		1.4	7.3	54.1	27.2	10.0	5548	9256
Ireland		0.0	1.1	87.1	11.8	0.0	93	3
Greece		11.8	52.9	17.6	17.6	0.0	17	0
Spain	(1)	2.0	5.6	43.7	46.2	2.5	591	80
France		4.1	2.0	82.1	9.7	2.0	196	94
Italy		6.0	29.2	55.9	5.7	3.2	281	0
Cyprus		0.0	0.0	100.0	0.0	0.0	12	0
Lithuania		63.9	0.0	30.3	5.7	0.0	122	17
Luxembourg		0.0	0.0	100.0	0.0	0.0	8	0
Hungary		11.8	2.1	64.5	21.0	0.6	959	0
Malta		0.0	0.0	100.0	0.0	0.0	17	2
Netherlands	(2)	1.2	6.5	27.6	63.9	0.8	642	81
Austria		0.0	1.0	52.0	47.0	0.0	100	7
Slovakia		39.9	23.4	4.8	29.3	2.7	188	4
Finland		76.1	2.4	10.3	11.2	0.0	331	20
Sweden		53.1	0.7	36.2	9.4	0.5	552	39
United Kingdom	(3)	20.3	3.2	62.5	6.6	7.5	4280	585
Total		16.4	5.3	50.0	22.2	6.1	15143	10284

Notes:

 Only countries where there are clients reported with stimulants as primary drug are shown. 

 (1) Data refer to 2005. 

 (2) Data refer to outpatient treatment centres and low-threshold agencies. 

 (3) Data refer to collection period between 1.4.2005 and 31.3.2006. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2007 — TDI — outpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)